Clinical evidence
The research behind Activance’s spicule technology
Activance is built on peptide-coated spicule technology, and that technology has been studied in published clinical research. This page summarises that evidence in plain English.
One important point up front: these are independent studies on spicules in general, the delivery system Activance uses, not trials of Activance’s own products. They tell you why the approach works, not that any single Activance product has been through its own trial.
At a glance
The evidence at a glance
The published research includes six peer-reviewed studies carried out between 2015 and 2021, mostly in South Korea, with around 140 people in total. Between them they looked at how much active a spicule formula delivers into the skin, and at results for anti-ageing, pigmentation, acne and overall skin quality. The designs ranged from small pilot studies to a randomised controlled trial.
- Peer-reviewed studies, published between 2015 and 2021
- 6
- People took part in total, mostly in South Korea
- ~140
- People in each study, from small pilots to a randomised controlled trial
- 14–30
The core idea
The core idea: deeper delivery
An ordinary cream is blocked by the skin’s surface, so a lot of the active never gets in. Spicules create tiny channels that let more of it through.
Across the published studies, researchers reported meaningfully higher absorption with spicules than with a cream alone, and in one study about 40% more of the active was measured in the skin. This is the mechanism the rest of the results rest on.
Clinical evidence summary
Six published studies on spicules
Independent studies on spicule technology in general, not trials of the finished Activance products.
| Study (year) | Design | What it reported |
|---|---|---|
| Keratosis pilaris pilot (2015) | 20 people, 8 weeks | Smoother, less inflamed skin (around 40% less roughness reported) |
| Periocular anti-ageing, Ha et al. (2017) | 20 people, split-face, 4 weeks | Less visible eye wrinkles and firmer, denser skin than the control cream |
| Deer antler extract, Kang et al. (2019) | 30 people, 2 weeks | Firmer, more hydrated skin with spicules than the same cream without them |
| Acne, Lee and Choi (2019) | 14 people, 12 weeks | Clearer skin, with roughly half as many lesions by week 12 |
| Skin quality, Han et al. (2020) | 25 people, 4 weeks | Better texture and hydration, more active reaching the skin, low irritation |
| Multi-benefit cohort, Han and Kim (2021) | 30 people, 4 weeks | Most people saw improvement across wrinkles, firmness, hydration and tone |
By concern
What the studies found, by concern
-
Anti-ageing
Studies on the eye area and face reported less visible fine lines and firmer, denser-looking skin, with the spicule formula outperforming a matched cream without spicules.
Related: Age Renewal Concentrate · Eye Contour
-
Pigmentation and skin quality
Studies reported more even tone, better hydration and smoother texture, which fits the idea that more of the brightening and hydrating actives are reaching the skin.
Related: Supabright Cream · Lip Lightener
-
Acne
A 12-week study reported clearer skin over time, with fewer lesions and less follicular build-up, from the exfoliating and delivery effects together.
Safety
Safety across the studies
The safety picture was consistent.
The most common effect was a mild, short-lived tingle or redness that settled within minutes to a couple of hours.
Across roughly 140 participants, no severe reactions, infections or scarring were reported.
Irritation was more likely with larger spicules, higher concentrations or aggressive rubbing, which is why gentle application matters.
Compared
How this compares to microneedling
Spicules use the same basic idea as microneedling, creating tiny channels so actives get in.
Microneedling session
- Deeper
- Supervised session
- Cost and downtime
Spicules
- Far gentler and shallower
- At home or in a clinic
- No session cost or downtime
The research positions spicules as a lighter, everyday option, not a replacement for a procedure in severe cases.
Limitations
Honest limitations
This evidence is encouraging but early.
- 14–30people in each study
- 2–12weeks: mostly short
- 1region for most studies
- 1randomised controlled trial
Larger, longer, multi-centre studies are still needed to confirm the long-term benefits. These results describe spicule technology in general and are not a guarantee of how any individual will respond. Your own results depend on your skin, your concern and consistent use.
Please note
Important note
Activance products are cosmetic skincare, not a medical treatment, and this page reports research on the spicule delivery technology rather than trials of the finished Activance products. For advice about your skin, speak to a dermatologist.
Explore the Activance range
Complete care for your skin.
Discover the full range of Activance products for targeted skin concerns, powered by peptide-coated spicules.
View all products